Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases-Reference-Cited by-同舟云学术

Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases

Published:2020-04 Issue:2 Volume:524 Page:332-339
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Nohara Hirofumi,Nakashima Ryunosuke,Kamei Shunsuke,Fujikawa Haruka,Ueno-Shuto Keiko,Kawakami Taisei,Eto Yuka,Suico Mary Ann,Li Jian-Dong,Kai Hirofumi,Shuto Tsuyoshi

Funder

Japan Society for the Promotion Science (JSPS) KAKENHI

JSPS Program on Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation

Program for Leading Graduate Schools HIGO (Health life science: Interdisciplinary

Glocal Oriented

MEXT, Japan

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference32 articles.

1. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic β-cells;Peyot;PLoS One,2009